1. Home
  2. NFG vs RGEN Comparison

NFG vs RGEN Comparison

Compare NFG & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Fuel Gas Company

NFG

National Fuel Gas Company

HOLD

Current Price

$81.59

Market Cap

7.3B

Sector

Utilities

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$162.51

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NFG
RGEN
Founded
1902
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NFG
RGEN
Price
$81.59
$162.51
Analyst Decision
Hold
Buy
Analyst Count
5
10
Target Price
$91.20
$174.90
AVG Volume (30 Days)
587.9K
701.7K
Earning Date
01-28-2026
10-28-2025
Dividend Yield
2.64%
N/A
EPS Growth
576.19
N/A
EPS
5.68
0.03
Revenue
$2,277,541,000.00
$707,890,000.00
Revenue This Year
$22.37
$17.84
Revenue Next Year
$22.03
$12.57
P/E Ratio
$14.27
$5,259.20
Revenue Growth
17.11
11.74
52 Week Low
$59.01
$102.97
52 Week High
$94.13
$182.52

Technical Indicators

Market Signals
Indicator
NFG
RGEN
Relative Strength Index (RSI) 47.73 54.15
Support Level $80.69 $156.01
Resistance Level $82.87 $165.02
Average True Range (ATR) 1.22 4.65
MACD 0.03 -1.07
Stochastic Oscillator 22.15 43.33

Price Performance

Historical Comparison
NFG
RGEN

About NFG National Fuel Gas Company

National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: